Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition

Hofmann, Irmgard; Baum, Anke; Hofmann, Marco H.; Trapani, Francesca; Reichel-Voda, Claudia; Ehrensperger, Diane; Aichinger, Martin; Ebner, Florian; Budano, Nicole; Schweifer, Norbert; Sykora, Martina; Depla, Erik; Boucneau, Joachim; Gschwind, Andreas; Kraut, Norbert; Hilberg, Frank; Kunkele, Klaus-Peter

Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition

Autor(en):

Hofmann, Irmgard; Baum, Anke; Hofmann, Marco H.; Trapani, Francesca; Reichel-Voda, Claudia; Ehrensperger, Diane; Aichinger, Martin; Ebner, Florian; Budano, Nicole; Schweifer, Norbert; Sykora, Martina; Depla, Erik; Boucneau, Joachim; Gschwind, Andreas; Kraut, Norbert; Hilberg, Frank; Kunkele, Klaus-Peter

Tübinger Autor(en):

Sykora, Martina

Erschienen in:

Journal of Pharmacology and Experimental Therapeutics (2023), Bd. 384, H. 3, S. 331-342

Verlagsangabe:

Amer Soc Pharmacology Experimental Therapeutics

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1124/jpet.122.001255

ISSN:

0022-3565